Intuitive Surgical (NASDAQ:ISRG) EVP Myriam Curet Sells 105 Shares of Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Myriam Curet sold 105 shares of the firm’s stock in a transaction that occurred on Tuesday, March 10th. The stock was sold at an average price of $493.95, for a total transaction of $51,864.75. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.

Myriam Curet also recently made the following trade(s):

• On Wednesday, February 11th, Myriam Curet sold 421 shares of Intuitive Surgical stock. The stock was sold at an average price of $494.96, for a total value of $208,378.16.
• On Tuesday, February 10th, Myriam Curet sold 105 shares of Intuitive Surgical stock. The shares were sold at an average price of $494.65, for a total value of $51,938.25.
• On Thursday, January 29th, Myriam Curet sold 126 shares of Intuitive Surgical stock. The stock was sold at an average price of $520.02, for a total value of $65,522.52.
• On Tuesday, January 27th, Myriam Curet sold 230 shares of Intuitive Surgical stock. The stock was sold at an average price of $532.61, for a total value of $122,500.30.

Intuitive Surgical Trading Down 2.3%

Shares of NASDAQ:ISRG traded down $11.21 on Thursday, hitting $481.66. The company had a trading volume of 363,897 shares, compared to its average volume of 1,992,339. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $603.88. The business has a 50 day moving average of $516.79 and a 200 day moving average of $512.60. The company has a market cap of $171.05 billion, a PE ratio of 61.01, a PEG ratio of 3.75 and a beta of 1.66.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The business had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.72 billion. During the same quarter last year, the company earned $2.21 earnings per share. The business’s revenue for the quarter was up 18.8% compared to the same quarter last year. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Institutional Investors Weigh In On Intuitive Surgical

Several hedge funds have recently modified their holdings of the stock. Newbridge Financial Services Group Inc. boosted its holdings in shares of Intuitive Surgical by 300.0% in the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 33 shares during the last quarter. Holos Integrated Wealth LLC acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth $25,000. Tobam raised its position in shares of Intuitive Surgical by 666.7% in the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 40 shares during the period. Kilter Group LLC acquired a new position in Intuitive Surgical in the second quarter valued at $27,000. Finally, Olistico Wealth LLC acquired a new position in Intuitive Surgical in the fourth quarter valued at $28,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Key Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Citi upgraded ISRG to Buy and set a $590 price target, signaling near-term upside and helping lift sentiment toward the stock. Citigroup upgrades Intuitive Surgical (ISRG)
• Positive Sentiment: Several bullish analyst pieces highlight ongoing momentum from the da Vinci 5 rollout, recurring revenue from instruments/software, and upside from Ion/SP platforms as drivers for continued procedure and revenue growth. Intuitive Surgical Poised for Growth in 2026 on da Vinci 5 Momentum
• Positive Sentiment: Coverage noting ISRG’s strong Q4 results (19% revenue growth, EPS beat) and positive momentum is keeping investor interest elevated and helped the stock outperform peers on a strong trading day. Intuitive Surgical Inc. stock outperforms competitors on strong trading day
• Neutral Sentiment: Bullish long-form analysis argues the company still has “massive growth ahead,” reinforcing long-term case but not changing near-term valuation debates. Intuitive Surgical: The Robotic Surgery Leader Still Has Massive Growth Ahead
• Neutral Sentiment: Valuation-focused pieces note that despite strong fundamentals and multi-year returns, near-term momentum has cooled and ISRG trades above its historical P/E—investors should weigh growth vs. elevated multiples. Assessing Intuitive Surgical (ISRG) Valuation As Shares Tread Water Despite Growth
• Negative Sentiment: The Fool and other coverage flag management’s guidance for a deceleration in worldwide da Vinci procedure growth in 2026 — a potential drag on forward growth expectations. Intuitive Surgical Stock: Buy, Sell, or Hold?
• Negative Sentiment: Company insiders (SVP and others) have been selling multiple lots recently, which can be read as profit-taking and may damp investor confidence despite the strong public narrative. SEC filing: Insider Sale Disclosures

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on ISRG shares. Zacks Research raised shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research report on Thursday, February 19th. Truist Financial lifted their target price on shares of Intuitive Surgical from $620.00 to $650.00 and gave the stock a “buy” rating in a research note on Thursday, December 18th. Raymond James Financial boosted their price target on Intuitive Surgical from $603.00 to $615.00 and gave the company an “outperform” rating in a report on Friday, January 23rd. Wall Street Zen lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Saturday, February 7th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Intuitive Surgical in a report on Monday, December 29th. Two analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, six have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $615.86.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.